Atika Capital Management LLC
13F filer · CIK 0001599731Reported Aug 13, 2026
Net buyer this quarter
13F portfolio value$1.52BU.S. long equity reported on 13F
Positions6228 new · 17 closed
Net flow last quarter+$217MBuys minus sells
Top 10 positions weight37.3%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 13, 202662 positions | |||||
| $223M | 14.66% | 0.17% | Not reported | Q2 2023 | |
| $77.1M | 5.07% | 0.04% | +49.3% | Q3 2025 | |
| $55.5M | 3.65% | 0.01% | Not reported | Q1 2023 | |
| $49.3M | 3.24% | 0.00% | Not reported | Q3 2015 | |
| $36.9M | 2.42% | 0.01% | Not reported | Q3 2023 | |
| $33.6M | 2.21% | 0.69% | +82.1% | Q4 2024 | |
| $27.2M | 1.78% | 0.14% | +98.9% | Q1 2019 | |
| $23.9M | 1.57% | 0.03% | +11.7% | Q3 2025 | |
| $22.8M | 1.50% | 0.02% | Not reported | Q2 2016 | |
| $17.7M | 1.16% | 0.96% | New | Q2 2026 | |
| $17.3M | 1.14% | 0.01% | Not reported | Q1 2024 | |
| $17.2M | 1.13% | 0.03% | +96.5% | Q4 2025 | |
| $16.9M | 1.11% | 0.01% | -29.8% | Q1 2026 | |
| $16.5M | 1.08% | 0.04% | New | Q2 2026 | |
| $16.3M | 1.07% | 0.10% | +219.0% | Q2 2018 | |
| $16.1M | 1.06% | 0.30% | +28.1% | Q4 2025 | |
| $15.4M | 1.01% | 0.12% | Not reported | Q2 2022 | |
| $14.9M | 0.98% | 0.04% | -7.8% | Q1 2015 | |
| $14.8M | 0.97% | 0.04% | -38.4% | Q4 2024 | |
| $13.4M | 0.88% | 0.06% | Not reported | Q2 2025 | |
| $12.9M | 0.84% | 0.00% | Not reported | Q4 2013 | |
| $12.1M | 0.80% | 0.04% | +23.1% | Q2 2025 | |
| $11.9M | 0.78% | 0.13% | Not reported | Q1 2024 | |
| $11.2M | 0.74% | 0.06% | +1.3% | Q1 2026 | |
| $11.1M | 0.73% | 0.17% | New | Q2 2026 | |
| $11.1M | 0.73% | 0.77% | +108.4% | Q4 2024 | |
| $10.5M | 0.69% | 0.16% | -7.2% | Q4 2025 | |
| $10.5M | 0.69% | 0.06% | -34.6% | Q2 2022 | |
| $10.5M | 0.69% | 0.00% | +0.7% | Q4 2015 | |
| $10.4M | 0.68% | Not reported | +162.6% | Q1 2024 | |
| $10.2M | 0.67% | 0.41% | New | Q2 2026 | |
| $9.96M | 0.65% | 0.01% | New | Q2 2026 | |
| $9.52M | 0.63% | 0.16% | -56.5% | Q1 2026 | |
| $9.35M | 0.61% | 0.05% | -46.2% | Q4 2025 | |
| $8.62M | 0.57% | 0.08% | New | Q2 2026 | |
| $7.99M | 0.53% | 0.15% | New | Q2 2026 | |
| $7.68M | 0.50% | 0.03% | Not reported | Q4 2022 | |
| $7.66M | 0.50% | 0.01% | Not reported | Q1 2020 | |
| $7.62M | 0.50% | Not reported | Not reported | Q2 2023 | |
| $7.61M | 0.50% | 0.10% | Not reported | Q3 2025 | |
| $7.46M | 0.49% | Not reported | Not reported | Q4 2025 | |
| $7.45M | 0.49% | 0.05% | New | Q2 2026 | |
| $7.19M | 0.47% | 0.07% | +1.3% | Q2 2016 | |
| $6.95M | 0.46% | 0.02% | Not reported | Q3 2022 | |
| $5.74M | 0.38% | 0.09% | New | Q2 2026 | |
| $5.57M | 0.37% | 0.23% | Not reported | Q1 2024 | |
| $5.14M | 0.34% | 0.04% | -9.7% | Q1 2026 | |
| $4.55M | 0.30% | 0.13% | +11.1% | Q4 2024 | |
| $4.54M | 0.30% | 22.22% | New | Q2 2026 | |
| $4.32M | 0.28% | 0.05% | New | Q2 2026 | |
| Q1 2026Reported May 14, 202651 positions | |||||
| $167M | 20.96% | 0.17% | +4.7% | Q2 2023 | |
| $37.8M | 4.75% | 0.00% | Not reported | Q3 2015 | |
| $26.4M | 3.31% | 0.02% | Not reported | Q2 2016 | |
| $21.3M | 2.68% | 0.38% | +45.8% | Q4 2024 | |
| $21M | 2.63% | 0.02% | +3.1% | Q3 2025 | |
| $18.5M | 2.33% | 0.07% | +2.9% | Q4 2024 | |
| $17.3M | 2.17% | 0.00% | Not reported | Q4 2013 | |
| $16.9M | 2.13% | 0.03% | -27.3% | Q3 2025 | |
| $16.9M | 2.12% | 0.09% | -24.2% | Q2 2022 | |
| TPTERNTerns Pharmaceuticals, Inc. | $15.8M | 1.99% | 0.26% | -6.6% | Q4 2025 |
| $14.4M | 1.80% | 0.04% | -33.5% | Q1 2015 | |
| $13.4M | 1.68% | Not reported | +18.4% | Q2 2020 | |
| $12.4M | 1.56% | Not reported | +2.5% | Q4 2015 | |
| $11.3M | 1.42% | 0.17% | -42.1% | Q4 2025 | |
| $11.3M | 1.42% | 0.46% | New | Q1 2026 | |
| $10.8M | 1.36% | 0.24% | -4.3% | Q4 2025 | |
| $10.2M | 1.28% | 0.01% | New | Q1 2026 | |
| $9.1M | 1.14% | 0.00% | -45.4% | Q4 2015 | |
| $9.06M | 1.14% | 0.09% | -8.4% | Q4 2025 | |
| $9.02M | 1.13% | 0.07% | -29.8% | Q2 2016 | |
| $8.85M | 1.11% | 0.04% | +31.6% | Q2 2025 | |
| $8.41M | 1.06% | 0.07% | -15.7% | Q1 2019 | |
| $7.8M | 0.98% | 0.01% | -24.2% | Q1 2020 | |
| $7.5M | 0.94% | Not reported | +6.7% | Q2 2023 | |
| $7.32M | 0.92% | 0.03% | Not reported | Q1 2015 | |
| $7.24M | 0.91% | 0.07% | New | Q1 2026 | |
| $6.83M | 0.86% | 0.02% | Not reported | Q3 2022 | |
| $6.55M | 0.82% | 0.10% | -27.8% | Q3 2025 | |
| $6.27M | 0.79% | 0.04% | +628.5% | Q4 2025 | |
| $5.9M | 0.74% | 0.04% | -56.1% | Q3 2024 | |
| $5.75M | 0.72% | 0.23% | -21.4% | Q1 2024 | |
| $5.72M | 0.72% | Not reported | Not reported | Q4 2013 | |
| $5.67M | 0.71% | 0.09% | +31.1% | Q3 2015 | |
| $5.52M | 0.69% | 0.01% | +38.5% | Q4 2025 | |
| $5.28M | 0.66% | 0.03% | -26.8% | Q4 2025 | |
| $5.13M | 0.64% | 0.04% | -37.1% | Q4 2025 | |
| $5.11M | 0.64% | 0.06% | New | Q1 2026 | |
| $4.4M | 0.55% | 0.00% | -40.2% | Q1 2024 | |
| $4.37M | 0.55% | 0.03% | -7.4% | Q2 2018 | |
| $4.1M | 0.51% | 0.37% | -20.2% | Q4 2024 | |
| $3.76M | 0.47% | 0.12% | New | Q1 2026 | |
| $3.48M | 0.44% | 0.06% | -35.3% | Q1 2023 | |
| $3.37M | 0.42% | Not reported | -33.1% | Q1 2024 | |
| $3.33M | 0.42% | 0.22% | New | Q1 2026 | |
| $3.21M | 0.40% | 0.04% | -47.6% | Q1 2024 | |
| $2.87M | 0.36% | 0.14% | Not reported | Q3 2014 | |
| $2.84M | 0.36% | 0.12% | -45.8% | Q4 2024 | |
| $2.74M | 0.34% | 0.04% | Not reported | Q3 2019 | |
| $2.61M | 0.33% | 0.02% | Not reported | Q4 2019 | |
| $2.31M | 0.29% | 0.04% | New | Q1 2026 | |
| Q4 2025Reported Feb 13, 202664 positions | |||||
| $103M | 10.85% | 0.17% | +3.8% | Q2 2023 | |
| $44.2M | 4.65% | 0.00% | Not reported | Q3 2015 | |
| $32.4M | 3.41% | 0.02% | 0.0% | Q2 2016 | |
| $22.4M | 2.36% | 0.06% | +220.1% | Q1 2015 | |
| $20M | 2.10% | 0.03% | +58.0% | Q2 2015 | |
| $19.8M | 2.08% | 0.15% | Not reported | Q1 2018 | |
| $18.8M | 1.98% | 0.12% | -49.9% | Q2 2022 | |
| $18.5M | 1.94% | 0.00% | -79.9% | Q4 2015 | |
| $18M | 1.89% | 0.31% | New | Q4 2025 | |
| $16.9M | 1.78% | 0.00% | Not reported | Q4 2013 | |
| $15.8M | 1.66% | 0.09% | -39.3% | Q3 2024 | |
| $14.3M | 1.50% | 0.02% | -56.1% | Q3 2025 | |
| $14M | 1.48% | 0.04% | -25.0% | Q3 2025 | |
| $13.6M | 1.43% | 0.26% | +80.9% | Q4 2024 | |
| $13.5M | 1.42% | 0.00% | -3.2% | Q4 2022 | |
| $13.4M | 1.41% | 0.04% | -18.7% | Q2 2024 | |
| $13.2M | 1.39% | Not reported | Not reported | Q4 2015 | |
| TPTERNTerns Pharmaceuticals, Inc. | $13M | 1.37% | 0.29% | New | Q4 2025 |
| $12.2M | 1.28% | 0.07% | +41.8% | Q4 2024 | |
| $12M | 1.26% | 0.01% | -25.0% | Q1 2020 | |
| $11M | 1.16% | 0.08% | -18.8% | Q1 2019 | |
| $10.8M | 1.14% | Not reported | -44.0% | Q2 2020 | |
| $10.6M | 1.11% | 0.10% | +23.5% | Q2 2016 | |
| $10.4M | 1.10% | Not reported | -27.2% | Q1 2024 | |
| $10.4M | 1.09% | Not reported | Not reported | Q2 2023 | |
| $10.1M | 1.07% | 0.11% | +13.3% | Q2 2022 | |
| $9.37M | 0.99% | 0.03% | Not reported | Q3 2018 | |
| $8.92M | 0.94% | 0.48% | +51.1% | Q4 2024 | |
| $8.51M | 0.90% | 0.05% | New | Q4 2025 | |
| $8.11M | 0.85% | 0.15% | +65.1% | Q3 2025 | |
| $8.1M | 0.85% | 0.06% | New | Q4 2025 | |
| $8.09M | 0.85% | 0.06% | New | Q4 2025 | |
| $7.99M | 0.84% | 0.00% | -21.4% | Q1 2024 | |
| $7.51M | 0.79% | 0.14% | +3.6% | Q3 2025 | |
| $7.46M | 0.79% | 0.02% | Not reported | Q4 2024 | |
| $7.42M | 0.78% | 0.07% | -20.3% | Q1 2024 | |
| $7.18M | 0.76% | 0.30% | Not reported | Q1 2024 | |
| $7M | 0.74% | 0.10% | New | Q4 2025 | |
| $6.62M | 0.70% | 0.04% | -54.1% | Q3 2017 | |
| $6.52M | 0.69% | 0.02% | Not reported | Q3 2022 | |
| $6.27M | 0.66% | 0.19% | Not reported | Q2 2021 | |
| $5.89M | 0.62% | 0.04% | +31.5% | Q2 2025 | |
| $5.82M | 0.61% | 0.02% | -57.4% | Q1 2025 | |
| $5.54M | 0.58% | 0.31% | New | Q4 2025 | |
| $5.45M | 0.57% | 0.03% | -1.7% | Q2 2025 | |
| $5.43M | 0.57% | 0.22% | Not reported | Q4 2024 | |
| $4.95M | 0.52% | Not reported | New | Q4 2025 | |
| $4.75M | 0.50% | Not reported | -10.5% | Q1 2024 | |
| $4.55M | 0.48% | Not reported | +106.4% | Q3 2025 | |
| $4.52M | 0.48% | 0.11% | New | Q4 2025 | |
| Q3 2025Reported Nov 13, 202575 positions | |||||
| $92.5M | 7.45% | 0.16% | Not reported | Q2 2023 | |
| $87.2M | 7.02% | 0.00% | -0.3% | Q4 2015 | |
| $85.5M | 6.88% | 0.00% | +4.4% | Q4 2015 | |
| $43.9M | 3.53% | 0.03% | +0.6% | Q2 2018 | |
| $43.2M | 3.48% | 0.11% | -5.6% | Q1 2014 | |
| $40.1M | 3.23% | 0.24% | +3.3% | Q2 2022 | |
| $33.7M | 2.71% | 0.02% | -11.6% | Q1 2017 | |
| $31.4M | 2.53% | 0.00% | Not reported | Q3 2015 | |
| $31.2M | 2.51% | 0.03% | Not reported | Q2 2024 | |
| $29.5M | 2.37% | 0.15% | +15.9% | Q3 2024 | |
| $27.9M | 2.25% | 0.06% | New | Q3 2025 | |
| $26.1M | 2.10% | 0.02% | -0.3% | Q2 2024 | |
| $26.1M | 2.10% | Not reported | -6.6% | Q4 2013 | |
| $25.6M | 2.06% | 0.02% | -4.0% | Q2 2016 | |
| $24.1M | 1.94% | 0.04% | -0.8% | Q1 2024 | |
| $21.6M | 1.74% | 0.00% | +50.0% | Q4 2013 | |
| $21M | 1.69% | Not reported | +42.5% | Q2 2020 | |
| $20.2M | 1.63% | 0.08% | +158.8% | Q2 2025 | |
| $19.7M | 1.59% | 0.02% | +30.7% | Q4 2021 | |
| VPVRNAVerona Pharma plc | $18.8M | 1.51% | 0.03% | -17.2% | Q3 2024 |
| $18.5M | 1.49% | 0.02% | -20.7% | Q1 2020 | |
| $17.3M | 1.40% | 0.05% | -44.5% | Q1 2025 | |
| $17.3M | 1.39% | 0.37% | -33.5% | Q2 2016 | |
| $17.2M | 1.38% | Not reported | -4.8% | Q1 2024 | |
| CTCDTXCidara Therapeutics, Inc. | $15.1M | 1.21% | 0.54% | New | Q3 2025 |
| $13.9M | 1.12% | 0.65% | +15.9% | Q2 2018 | |
| $13.8M | 1.11% | 0.00% | +25.7% | Q1 2020 | |
| $13.8M | 1.11% | 0.00% | Not reported | Q4 2022 | |
| $13.7M | 1.10% | 0.04% | Not reported | Q2 2024 | |
| $13.7M | 1.10% | 0.01% | +73.6% | Q1 2018 | |
| $13.3M | 1.07% | 0.09% | +198.2% | Q3 2017 | |
| $12.3M | 0.99% | Not reported | Not reported | Q2 2023 | |
| $11.7M | 0.94% | 0.02% | +13.1% | Q2 2015 | |
| $11.7M | 0.94% | 0.06% | New | Q3 2025 | |
| $10.1M | 0.82% | 0.02% | -19.8% | Q2 2014 | |
| $9.93M | 0.80% | 0.00% | +5.0% | Q1 2024 | |
| $8.79M | 0.71% | 0.38% | -27.3% | Q2 2025 | |
| $8.46M | 0.68% | 0.00% | Not reported | Q4 2023 | |
| $8.41M | 0.68% | 0.05% | -19.7% | Q4 2024 | |
| $8.31M | 0.67% | 0.11% | +49.1% | Q1 2019 | |
| $7.48M | 0.60% | 0.03% | Not reported | Q3 2018 | |
| $7.46M | 0.60% | 0.01% | New | Q3 2025 | |
| $7.14M | 0.58% | 0.13% | +5.2% | Q1 2023 | |
| $7.04M | 0.57% | 0.08% | Not reported | Q2 2016 | |
| $6.6M | 0.53% | 0.22% | New | Q3 2025 | |
| $6.58M | 0.53% | 0.01% | Not reported | Q3 2022 | |
| $5.95M | 0.48% | 0.10% | +6.2% | Q2 2022 | |
| $5.86M | 0.47% | 0.11% | Not reported | Q1 2024 | |
| $5.51M | 0.44% | 0.13% | New | Q3 2025 | |
| $5.49M | 0.44% | 0.14% | Not reported | Q4 2020 | |
Premium opens every quarter this fund has filed